MENLO PARK, Calif., Jan. 11 /PRNewswire/ -- ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the launch of its new Dip and Read Residual Protein A Detection Kit for use on the company's Octet platform. The new assay enables drug developers to accurately identify and measure levels of Protein A with unprecedented speed and minimal hands-on time. The company also announced the introduction of its Sidekick Offline Biosensor Immobilization Station, which enables offline loading of reagents on biosensors, in tandem with any Octet instrument, for enhanced efficiency and assay performance.
The Dip and Read Residual Protein A Detection Kit consists of biosensors and all the reagents required to quantitate Protein A or biosimilars such as MabSelect SuRe(TM), in the presence of human IgG.
"Protein A detection is a critical quality control step during drug development and manufacturing, but traditional methods are labor-intensive, complicated and time-consuming," said Christopher Silva, ForteBio's vice president of marketing. "Our new Dip and Read Residual Protein A Detection Kit offers the same sensitivity levels as existing methods, but requires significantly less hands-on time and can be completed in half the time."
The new Sidekick Offline Biosensor Immobilization Station works alongside any Octet instrument and enables offline, simultaneous and uniform sample loading on all 96 biosensors on a biosensor tray. This increases efficiency by freeing up the Octet system for other uses. Additionally, the instrument shakes the samples, while keeping the biosensors immobile, which decreases the required incubation time by one half, thereby doubling the biosensor preparation productivity. Further, for sandwich assays, this process significantly increases the assay's sensitivity.
|SOURCE ForteBio, Inc.|
Copyright©2010 PR Newswire.
All rights reserved